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Introduction
============

The pineal gland is a small endocrine gland located in the epithalamus region. It produces melatonin, which helps in modulating the sleep cycle. Malignancies of the pineal gland arising from itself are very rare. The spectrum of tumors arising in this region is broad. Almost more than 17 heterogeneous tumors can arise in this region.

To our knowledge, only five cases of oligodendroglioma of the pineal region have been reported in the literature. This is the sixth case, which makes this incidence a unique presentation.

Case presentation
=================

A 45-year-old man presented to the outpatient department with complaints of a frontal headache for the last four months. His pain was 6/10 on the intensity scale. The headache usually occurred in the morning, was severe in intensity, was associated with dizziness, and usually responded to over-the-counter pain medication. For past four months, the patient reported visual disturbances in the form of blurry vision, but on thorough examination by the ophthalmology department, a peripheral visual defect was ruled out and magnetic resonance imaging (MRI) of the brain was advised.

The patient underwent a brain MRI and was referred to the medicine outpatient department where it was revealed that the patient had a mass in the pineal region as shown in Figure [1](#FIG1){ref-type="fig"} and the CT scan in Figure [2](#FIG2){ref-type="fig"}.
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His baselines including the complete blood count, basic metabolic panel, liver function test, urine detailed report and chest X-ray were within normal limits. The patient denied any family history of brain tumors. His past medical history included diabetes and hypertension for the last five years. Both were well controlled on losartan and Glucophage, respectively.

Neurological consult was sought and the patient was advised to get a brain biopsy done to channel the diagnosis into effective treatment options. The sample was processed and sent for histology. It showed a neoplastic lesion composed of polygonal cells against a fibrillary background. These neoplastic cells had a round nucleus exhibiting a moderate degree of pleomorphism and surrounded by a perinuclear halo. Significantly increased mitotic activity was appreciated. The immunohistochemical analysis came with positive CD 57, CD99, CD 10, diffuse positive for GFAP (glial fibrillary acidic protein), weak positivity for synaptophysin, and a high Ki-67 index (around 17 percent of cells). Cytokeratin and extractable nuclear antigen (ENA) immunohistochemical stains were also negative. Fluorescent insitu hybridization (FISH) performed on a small number of cells showed deletion of 1p and 19q.

In the light of all these findings, a diagnosis of oligodendroglioma was concluded. The patient was offered radiation and chemotherapy options like procarbazine, methyl-1-(2-chloroethyl)-1-nitrosourea (CCNU) and vincristine (also known as PCV therapy). After a detailed discussion, the patient and his family declined both options. Surgical management was also proposed but the patient deferred it.

Discussion
==========

Oligodendrogliomas, a type of glioma, are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell. Overall, they constitute less than 20% of all intracranial tumors and less than 25% of gliomas \[[@REF1]\]. Their prevalence is mostly among adults during midlife and rare in the pediatric population, occurring exclusively in the cerebral hemisphere predominantly in the male population with a male to female ratio of 1.28:1 \[[@REF1]-[@REF3]\]. Most cases have been reported in Caucasian, African American, and Hispanic populations. On diagnostic imaging, these tumors are mostly found in the temporal lobe in the pediatric population, while in adults they have been mostly reported in the frontal cortex region \[[@REF1]\]. They occur at a median age of 30 and the most common presenting symptoms are headache (78%), seizures (43%), motor symptoms (38%), and to a lesser extent behavioral changes \[[@REF4]-[@REF5]\].The pathologic grade of the tumor has been an essential element in determining the progression of symptoms and survival rate. Patients with low grade or pediatric patients with good performance status at initial presentation had a better survival rate following treatment \[[@REF4], [@REF6]\].

The pineal region is a complex anatomical site sheltering the pineal gland surrounded by the quadrigeminal plate and the confluence of the internal cerebral veins forming the vein of Galen \[[@REF7]\]. Although germinal cell tumors and pineal cell tumors form the majority of the histological tumors, more than 17 different tumors can arise in this location \[[@REF8]\]. A pie chart distribution of tumor and non-tumor lesions of the pineal gland by the histological sub type based on an observational study of 12 years is shown in Figure [3](#FIG3){ref-type="fig"} \[[@REF2]\].
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Gliomas are a very rare subtype of pineal region tumors; oligodendrogliomas of the pineal region, being a subtype of gliomas, further contribute to exclusively rare tumors with very few reported cases reported till date \[[@REF5], [@REF9]\].

As stated previously, the grade of the tumor determines the course of the disease and treatment, with the overall five-year progression-free survival rate being around 79% for low-grade tumors as compared to 39% for high-grade tumors \[[@REF3]\]. Pineal tumors and especially germinal tumors are chemosensitive and radiosensitive; care of these tumors is multidisciplinary involving surgery, chemotherapy, and radiotherapy \[[@REF3]-[@REF4], [@REF9]\]. Our patient was offered the treatment but he and his family members refused to agree to surgical resection or any form of chemo and radiotherapy. However, they did agree to frequent follow-ups after proper counseling as a part of palliative treatment.

To our knowledge, only five cases of oligodendroglioma of the pineal region have been reported in the literature. This is the sixth case, which makes this incidence a unique presentation. The findings of all previous five cases and the current case are compiled in Table [1](#TAB1){ref-type="table"}. The details of the five cases are mentioned after the literature review of the corresponding case \[[@REF2], [@REF10]\].

###### Cases of Oligodendroglioma in the Pineal Gland

  ------------------------- --------------------------- ---------------------------------------------------------------- ------------------------------ ----------------------------------------------------------------------------
  Age, Sex                  Month, Year of reporting    Presenting Symptoms                                              Histological Diagnosis         Treatment Given
  30, Male                  January, 2006               Not mentioned                                                    Anaplastic OD                  Not mentioned
  35, Female                January, 2006               Not mentioned                                                    Anaplastic OD                  Not mentioned
  59, Female                September, 2006             Headache + intermittent confusion + memory disturbance           Anaplastic OD                  Surgical resection + chemo- & radiotherapy
  37, Female                September, 2010             Diplopia                                                         Low-grade OD                   Surgical resection
  22, Female                February, 2015              Headache of increasing severity for one month                    Low-grade OD                   Surgical resection
  45, Male (Current Case)   July, 2017 (Current Case)   Frontal headache + transient visual obscuration (Current Case)   High-grade OD (Current Case)   Chemo- & radiotherapy (Patient denied surgical resection)   (Current Case)
  ------------------------- --------------------------- ---------------------------------------------------------------- ------------------------------ ----------------------------------------------------------------------------

Conclusions
===========

We present this case of oligodendroglioma in the pineal gland as it is the sixth case reported till now. This case will serve to remind physicians about its occurrence and presentation. A headache as the initial presentation of many illnesses should be given due consideration and one should rule out every possible cause. This, in turn, would help us to design a management layout for such an exceedingly rare tumor.
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